These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 2502367)
1. Exaggerated cholestasis and hepatic fibrosis following simultaneous administration of chlorpromazine and sodium valproate. Bach N; Thung SN; Schaffner F; Tobias H Dig Dis Sci; 1989 Aug; 34(8):1303-7. PubMed ID: 2502367 [No Abstract] [Full Text] [Related]
2. Acute pancreatitis and diabetic ketoacidosis in non-diabetic person while on treatment with sodium valproate, chlorpromazine and haloperidol. Laghate VD; Gupta SB J Assoc Physicians India; 2004 Mar; 52():257-8. PubMed ID: 15636323 [TBL] [Abstract][Full Text] [Related]
3. A reversible parkinsonian syndrome and hepatotoxcity following addition of carbamazepine to sodium valproate. Froomes PR; Stewart MR Aust N Z J Med; 1994 Aug; 24(4):413-4. PubMed ID: 7980246 [No Abstract] [Full Text] [Related]
4. Adverse Outcome Pathways and Drug-Induced Liver Injury Testing. Vinken M Chem Res Toxicol; 2015 Jul; 28(7):1391-7. PubMed ID: 26119269 [TBL] [Abstract][Full Text] [Related]
5. [Agranulocytosis and simultaneous cholestatic jaundice induced by sodium valproate in an elderly woman]. Védrine L; Biance N; Souleau B; Nedellec G; de Revel T Presse Med; 2001 Oct; 30(28):1404. PubMed ID: 11688206 [No Abstract] [Full Text] [Related]
6. Peroxisomal and mitochondrial proliferation and increased alanine: glyoxylate aminotransferase activity in human liver after chlorpromazine-induced cholestasis. Cooper PJ; Danpure CJ; Simpson KJ Biochem Soc Trans; 1989 Dec; 17(6):1071-2. PubMed ID: 2628084 [No Abstract] [Full Text] [Related]
7. Simultaneous appearance of agranulocytosis and cholestatic jaundice following chlorpromazine treatment. Sidi Y; Douer D; Pinkhas J Med Interne; 1989; 27(1):69-71. PubMed ID: 2749161 [TBL] [Abstract][Full Text] [Related]
8. Fatal hepatic failure and sodium valproate. Le Bihan G; Bourreille J; Sampson M; Leroy J; Szekely AM; Coquerel A Lancet; 1980 Dec; 2(8207):1298-9. PubMed ID: 6108469 [No Abstract] [Full Text] [Related]
9. Hepatic fibrosis following long acting nicotinic acid therapy: a case report. Kohn RM; Montes M Am J Med Sci; 1969 Aug; 258(2):94-9. PubMed ID: 5805238 [No Abstract] [Full Text] [Related]
16. Inhibition of PAR-4 and P2Y12 receptor-mediated platelet activation produces distinct hepatic pathologies in experimental xenobiotic-induced cholestatic liver disease. Joshi N; Kopec AK; Ray JL; Luyendyk JP Toxicology; 2016 Jul; 365():9-16. PubMed ID: 27475285 [TBL] [Abstract][Full Text] [Related]
17. [Chronic intrahepatic cholestasis following chlorpromazine; treated using phenobarbital]. Nerad V; Skaunic V Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1976; 19(5):721-7. PubMed ID: 1088626 [No Abstract] [Full Text] [Related]
18. [Acute liver necrosis caused by valproate]. Zäh W; Rengeling M; Rühl G; Hackenberg K Dtsch Med Wochenschr; 1985 Jun; 110(24):956-9. PubMed ID: 3922731 [TBL] [Abstract][Full Text] [Related]
19. [Causes and types of cholestasis from a biopsy viewpoint]. Roschlau G Dtsch Z Verdau Stoffwechselkr; 1983; 43(2):49-55. PubMed ID: 6872919 [TBL] [Abstract][Full Text] [Related]